Polymax Special Precautions

Anemia should always be treated under medical supervision.
If the therapy does not succeed (hemoglobin increases by about 2-3 g/dl after 3 weeks), the treatment should be reconsidered.
Iron + Folic Acid (Vitamin B₉) capsules contain folic acid and can mask a vitamin B₁₂ deficiency. Due to the risk of irreversible neurological disorders, a possible vitamin B₁₂ deficiency should be excluded in anemic patients before starting therapy.
During the treatment with iron hydroxide polymaltose, dark discolouration of the faeces (stool) may occur, however this is not of clinical relevance.
Caution should be exercised in patients who receive repeated blood transfusions, since erythrocytes also supply iron, which can lead to iron overload. Infections or tumors may cause anemia. Since iron can be utilized only after correcting the primary disease, a benefit/risk evaluation is advisable.
Effects on ability to drive and use machines: No relevant studies were undertaken. However, iron hydroxide polymaltose complex is unlikely to have any effect on the ability to drive and use machines.
Use in Pregnancy & Lactation: See Use in Pregnancy & Lactation section for further information.
Use in Children: There are no data on the use of iron hydroxide polymaltose complex in children and adolescents aged 12 years and younger, and therefore it is not recommended.
Use in the Elderly: Clinical experience with iron hydroxide polymaltose in the elderly is limited. For use in elderly patients consult a medical practitioner.